Skip to content
2000
Volume 11, Issue 2
  • ISSN: 1570-1638
  • E-ISSN: 1875-6220

Abstract

The pharmaceutical industry is experiencing comeback sales growth due in large part to the industry’s R&D efforts that center on biologics drug development. To facilitate that effort, tools are being developed for more effective biologic drug development. At the forefront of this effort is epitope characterization, in particular epitope binning, primarily due to the role an epitope plays in drug function. Here we detail the financial advantages of epitope binning including (1) increased R&D productivity due to increased work in process, (2) reduced number of “dead-end”candidates, and (3) increasedability to reengineer antibodies based on the epitope. With the arrival of high throughput biosensors, this manuscript serves as a call to push epitope binning earlier in the biological drug discovery process.

Loading

Article metrics loading...

/content/journals/cddt/10.2174/1570163810666131124233827
2014-06-01
2025-09-12
Loading full text...

Full text loading...

/content/journals/cddt/10.2174/1570163810666131124233827
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test